ALK announced that children aged 4 and older living with severe allergies across the EU can now access the first and only needle-free adrenaline treatment for anaphylaxis, after… read more.
Families are feeling stressed, powerless and ‘forever in limbo’ as they wait months, or sometimes years, for Attention-Deficit Hyperactivity Disorder (ADHD) assessments, according to a new study. Research led by the University of Southampton and King’s College London examined… read more.
Novartis announced today that Cosentyx (secukinumab) received FDA approval for treating pediatric patients 12 years and older with moderate to severe hidradenitis suppurativa (HS), making it the only IL-17A inhibitor for this population. The… read more.
A global atlas mapping two key gut bacteria in infants around the world has uncovered a treasure trove of bacterial strains adapted to the infant gut and not… read more.
Texas Children’s once again continues to lead the nation in performing the most pediatric transplants, as reported by the Organ Procurement & Transplantation Network (OPTN), the country’s unique public-private… read more.
Researchers report that maternal vaccination with the mRNA COVID-19 vaccine is not associated with autism or other neurodevelopmental problems in children whose mothers were vaccinated immediately before or during pregnancy. The findings were… read more.
The FDA has accepted for priority review the supplemental biologic license application (sBLA) for Tzield (teplizumab-mzwv) to expand the current age indication from eight years and above, to… read more.
Researchers have shown for the first time that maternal antibodies are found not only in the blood of newborns, but also in the nasal mucosa. The international study,… read more.
The European Medicines Agency (EMA) has released a statement designed to clear up any remaining uncertainty about the use of paracetamol. In the EU, the drug watchdog says,… read more.
Fortress Biotech, Inc. announced that the U.S. Food and Drug Administration has approved ZYCUBO (copper histidinate, formerly known as CUTX-101) for the treatment of Menkes disease in pediatric… read more.
A new landmark study supports the safety of the common painkillers paracetamol and ibuprofen in the first year of life, and finds no link to eczema or bronchiolitis,… read more.
Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who received the injectable intramuscular antiviral medications cabotegravir and rilpivirine for nearly… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
